TABLE 2.
Age groupa | Parameterb | Values (%)
|
||||
---|---|---|---|---|---|---|
Individual serologic testsc
|
Combination of testsd
|
|||||
N | E | W | N-W | E-W | ||
Child | ||||||
Sensitivity (n = 8) | 88 | 100 | 100 | 88 | 100 | |
Specificity (n = 24) | 100 | 92 | 83 | 100 | 100 | |
Adult | ||||||
Sensitivity (n = 85) | 80 | 80 | 80 | 80 | 80 | |
Specificity (n = 85) | 93 | 62ef | 85 | 96 | 84e |
Serum samples from individuals from 1 to 14 years of age (Child) or from individuals 18 to 59 years of age (Adult).
Sensitivity, number of H5N1 virus-infected patients testing positive for antibody divided by the total number of patients with confirmed H5N1 infections tested. Specificity, number of control age-matched sera tested minus the number of control sera testing positive for antibody divided by total number of control sera.
Tests for determination of H5N1 virus positivity (N, microneutralization test; W, Western blotting; E, ELISA).
Combination of tests. Microneutralization test with A/Hong Kong/156/97 virus followed by Western blot confirmation with rHA of A/Hong Kong/156/97 virus (N-W) and ELISA with rHA of A/Hong Kong/156/97 virus followed by Western blot confirmation with rHA of A/Hong Kong/156/97 virus (E-W).
Number of samples, 50.
Statistical analysis for positive association between test result and known status of samples was not significant (Fisher exact test; P = 0.067). All other assays were significant (P = 0.003).